Global Thin-film Drug Delivery Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Thin-film Drug Delivery Market Insights, Forecast to 2034
Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
Market Analysis and InsightsGlobal Thin-film Drug Delivery Market
Global Thin-film Drug Delivery market is expected to reach to US$ 6675 million in 2024, with a positive growth of %, compared with US$ 6345 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Thin-film Drug Delivery industry is evaluated to reach US$ 9099.6 million in 2029. The CAGR will be 5.3% during 2024 to 2029.
The Thin-film Drug Delivery market is driven by the growing need for convenient and patient-friendly drug delivery solutions. Thin-film drug delivery systems offer a unique way to administer medications through dissolvable or wearable films, providing benefits such as ease of use, discreetness, and potential for controlled release. The rise in chronic diseases and the need for personalized medicine contribute to market growth, as patients and healthcare providers seek innovative alternatives to traditional oral medications or injections. Moreover, advancements in thin-film technology and formulations align with improved drug stability, bioavailability, and patient adherence, fostering market adoption. However, the market also faces challenges, including the complexity of formulating drugs in thin-film formats and ensuring consistent drug release profiles. Additionally, addressing concerns related to regulatory approvals, scalability of manufacturing processes, and intellectual property can pose obstacles for manufacturers. To succeed, companies must focus on formulation expertise, rigorous quality control, and addressing the challenges to provide patients with reliable and effective thin-film drug delivery systems that enhance medication compliance and improve patient outcomes.
Report Covers
This report presents an overview of global Thin-film Drug Delivery market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Thin-film Drug Delivery market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
GSK
LTS
J&J
Indivior
Pfizer
Church & Dwight
tesa Labtec
Tapemark
Prestige
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
Segment by Type
Oral Thin Film
Transdermal Film
Others
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Thin-film Drug Delivery introduction, etc. Thin-film Drug Delivery Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Thin-film Drug Delivery
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Thin-film Drug Delivery Market
Global Thin-film Drug Delivery market is expected to reach to US$ 6675 million in 2024, with a positive growth of %, compared with US$ 6345 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Thin-film Drug Delivery industry is evaluated to reach US$ 9099.6 million in 2029. The CAGR will be 5.3% during 2024 to 2029.
The Thin-film Drug Delivery market is driven by the growing need for convenient and patient-friendly drug delivery solutions. Thin-film drug delivery systems offer a unique way to administer medications through dissolvable or wearable films, providing benefits such as ease of use, discreetness, and potential for controlled release. The rise in chronic diseases and the need for personalized medicine contribute to market growth, as patients and healthcare providers seek innovative alternatives to traditional oral medications or injections. Moreover, advancements in thin-film technology and formulations align with improved drug stability, bioavailability, and patient adherence, fostering market adoption. However, the market also faces challenges, including the complexity of formulating drugs in thin-film formats and ensuring consistent drug release profiles. Additionally, addressing concerns related to regulatory approvals, scalability of manufacturing processes, and intellectual property can pose obstacles for manufacturers. To succeed, companies must focus on formulation expertise, rigorous quality control, and addressing the challenges to provide patients with reliable and effective thin-film drug delivery systems that enhance medication compliance and improve patient outcomes.
Report Covers
This report presents an overview of global Thin-film Drug Delivery market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Thin-film Drug Delivery market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
GSK
LTS
J&J
Indivior
Pfizer
Church & Dwight
tesa Labtec
Tapemark
Prestige
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR
Segment by Type
Oral Thin Film
Transdermal Film
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Thin-film Drug Delivery introduction, etc. Thin-film Drug Delivery Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Thin-film Drug Delivery
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices